Assenagon Asset Management S.A. Stoke Therapeutics, Inc. Put Options Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding STOK
# of Institutions
144Shares Held
57MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$171 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$171 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$162 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$147 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$139 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.25B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...